The Fed, the Rotation, and Why IBD Is at Minimum Exposure
As the Fed decision sets up for a strong reaction, here’s what to watch. Plus, why IBD is at minimal market exposure while the Dow rallies.
As the Fed decision sets up for a strong reaction, here’s what to watch. Plus, why IBD is at minimal market exposure while the Dow rallies.
Semis up, drugs down. The Either/Or market is undefeated. But maybe the Fed can help move the market.
The current AI market, private capital raises and valuations, and why portfolio discipline is critical.
The demand picture remains strong, but market conditions mean focusing on support levels.
Corning is in disaster mode today. But should it be? Let’s looking into the report.
Ugly action in technology is dragging down names that have nothing to do with AI.
With staples stocks stuck in the pantry, this one is beating the sector and market, and serving up compelling risk-reward.
Though shares on under pressure on the news, there’s no long-term concern.
Four issues have arrived at the same time. But they are not the same problem. Here’s what to know.
After a stellar run, the SOX have looked terrible recently. Is this just a pause or something worse?